Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Lumiera Health Inc.
  6. News
  7. Summary
    NHP   CA5502541066

LUMIERA HEALTH INC.

(NHP)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021

10/27/2021 | 04:11pm EST

Lumiera Health Inc. reported earnings results for the third quarter and nine months ended August 31, 2021. For the third quarter, the company reported sales was CAD 0.107963 million compared to CAD 0.114272 million a year ago. Net loss was CAD 0.484565 million compared to CAD 0.17788 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to CAD 0.003 a year ago. For the nine months, sales was CAD 0.352601 million compared to CAD 0.358868 million a year ago. Net loss was CAD 0.52432 million compared to CAD 0.925558 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to CAD 0.015 a year ago.


ę S&P Capital IQ 2021
All news about LUMIERA HEALTH INC.
2021Lumiera ends fiscal year strong with sales in November 2021 up 59% compared to November..
AQ
2021Lumiera Health Appoints Louis Doyle to Board of Directors
AQ
2021Lumiera Health Announces Board Changes
CI
2021Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
2021LUMIERA HEALTH : new first of its kind pain relief cream, Awaye™, activates the body..
AQ
2021LUMIERA HEALTH : Launches New Direct-to-Consumer Platform, Closes Private Placement
MT
2021Lumiera Health Announces Launch of Its New Direct-To-Consumer Platform
CI
2021LUMIERA HEALTH : announces launch of its new Direct-to-Consumer platform
AQ
2021Lumiera Health Inc. announced that it has received CAD 0.55 million in funding from 931..
CI
2021LUMIERA HEALTH : announces Private Placement Extension
AQ
More news
Financials
Sales 2020 0,50 M 0,40 M 0,40 M
Net income 2020 -1,93 M -1,54 M -1,54 M
Net cash 2020 0,99 M 0,79 M 0,79 M
P/E ratio 2020 -1,90x
Yield 2020 -
Capitalization 2,55 M 2,04 M 2,04 M
EV / Sales 2019 18,8x
EV / Sales 2020 8,71x
Nbr of Employees -
Free-Float 61,6%
Chart LUMIERA HEALTH INC.
Duration : Period :
Lumiera Health Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Carlos Ponce Chief Executive Officer & Director
Simon Castonguay Controller
Kevin Cole Chairman
Louis Doyle Director
Marie BÚlanger Director
Sector and Competitors
1st jan.Capi. (M$)
LUMIERA HEALTH INC.-25.00%2
JOHNSON & JOHNSON-2.32%439 907
ROCHE HOLDING AG-3.75%322 066
PFIZER, INC.-8.37%303 712
ABBVIE INC.1.02%241 811
ELI LILLY AND COMPANY-10.55%223 992